Douglas Collins
Family Medicine · Cincinnati, OHNPI 1033407333
Payments from drug & device makers
Across 76 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$617
- Exact Sciences$97
- Pfizer$95
- Indivior Inc.$68
- Alkermes, Inc.$59
- Lilly USA, LLC$58
- plus $488 from 14 others
What the payments were for
- Food & beverage$1,482100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $617 |
| Exact Sciences | 5 | $97 |
| Pfizer | 6 | $95 |
| Indivior Inc. | 4 | $68 |
| Alkermes, Inc. | 2 | $59 |
| Lilly USA, LLC | 4 | $58 |
| Cranial Technologies, Inc | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 2 | $56 |
| AstraZeneca | 3 | $52 |
| Merck | 3 | $51 |
| Gilead | 3 | $42 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| GSK | 2 | $35 |
| Bayer | 2 | $28 |
| Almatica Pharma LLC | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| Insulet Corporation | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavyret$110
How this compares
$1,482 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 17 | $23,880 |
| TrulicityDulaglutide | 19 | $22,262 |
| XareltoRivaroxaban | 12 | $11,089 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $7,967 |
| Potassium Chloride | 26 | $2,111 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $1,001 |
| Atorvastatin Calcium | 85 | $898 |
| Pregabalin | 23 | $774 |
| Gabapentin | 51 | $686 |
| Lisinopril | 44 | $355 |
| Methocarbamol | 13 | $283 |
| Hydroxyzine Hcl | 12 | $275 |
| Torsemide | 16 | $246 |
| Metformin Hcl ErMetformin Hcl | 28 | $239 |
| Levothyroxine Sodium | 24 | $236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $58 | $22,26219 claims |
| GSKIncruse Ellipta | $35 | $7,96712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Cincinnati
- Michael ButcherCincinnati$18.3M
- Paul NugentCincinnati$4.9M
- Rajesh DavitCincinnati$2M
- Michael HeileCincinnati$272K
- Michael NossCincinnati$265K
- Amy MechleyCincinnati$120K
- Melissa SchroerCincinnati$116K
- William CoxCincinnati$52K
- Frank PerrinoCincinnati$49K
- Sean LyndCincinnati$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.